Ernst Th Scholten

Ernst Th Scholten

Auto-generated profile, based on publicly available information

Ernst Th Scholten

From the Department of Medical Imaging, Radboud Institute of Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2016 in Thorax
Verified
Journal Article
Open access
PDF file
UYUraujh Yousaf-Khan
Uraujh Yousaf-Khan
CACarlijn van der Aalst
Carlijn van der Aalst
PJPim A de Jong
Pim A de Jong
MHMarjolein Heuvelmans
Marjolein Heuvelmans
ESErnst Scholten
Ernst Scholten
HKHarry de Koning
Harry de Koning
Background In the USA annual lung cancer screening is recommended. However, the optimal screening strategy (eg, screening interval, screening rounds) is unknown. This study provides results of the fourth screening round after a 2.5-year interval in the Dutch-Belgian Lung Cancer Screening trial (NELSON). Methods Europe's largest, sufficiently powered randomised lung cancer screening trial was designed to determine whether low-dose CT screening reduces lung cancer mortality by ≥25% compared with no screening after 10 years of follow-up. The screening arm (n=7915) received screening at baseline, after 1 year, 2 years and 2.5 years. Performance of the NELSON screening strategy in the final fourth round was evaluated. Comparisons were made between lung cancers detected in the first three rounds, in the final round and during the 2.5-year interval. Results In round 4, 46 cancers were screen-detected and there were 28 interval cancers between the third and fourth screenings. Compared with the second round screening (1-year interval), in round 4 a higher proportion of stage IIIb/IV cancers (17.3% vs 6.8%, p=0.02) and higher proportions of squamous-cell, bronchoalveolar and small-cell carcinomas (p=0.001) were detected. Compared with a 2-year interval, the 2.5-year interval showed a higher non-significant stage distribution (stage IIIb/IV 17.3% vs 5.2%, p=0.10). Additionally, more interval cancers manifested in the 2.5-year interval than in the intervals of previous rounds (28 vs 5 and 28 vs 19). Conclusions A 2.5-year interval reduced the effect of screening: the interval cancer rate was higher compared with the 1-year and 2-year intervals, and proportion of advanced disease stage in the final round was higher compared with the previous rounds. Trial registration number ISRCTN63545820.

1 September 2020 in Radiology
Verified
Journal Article
Closed access
KMKeelin Murphy
Keelin Murphy
HSHenk Smits
Henk Smits
AKArnoud J. G. Knoops
Arnoud J. G. Knoops
MKMichael B. J. M. Korst
Michael B. J. M. Korst
TSTijs Samson
Tijs Samson
MRMatthieu Rutten
Matthieu Rutten
Background Chest radiography (CXR) may play an important role in triage for COVID-19, particularly in low-resource settings. Purpose To evaluate the performance of an artificial intelligence (AI) s...

1 August 2021 in Radiology
Verified
Journal Article
Closed access
KVKiran Vaidhya Venkadesh
Kiran Vaidhya Venkadesh
ASArnaud A. A. Setio
Arnaud A. A. Setio
ASAnton Schreuder
Anton Schreuder
ESErnst T. Scholten
Ernst T. Scholten
KCKaman Chung
Kaman Chung
CJColin Jacobs
Colin Jacobs
A deep learning algorithm, developed for malignancy risk estimation of pulmonary nodules detected at screening CT, demonstrated good discriminative performance in a large independent validation set. Background Accurate estimation of the malignancy risk of pulmonary nodules at chest CT is crucial for optimizing management in lung cancer screening. Purpose To develop and validate a deep learning...

1 January 2021 in Radiology
Verified
Journal Article
Closed access
NLNikolas Lessmann
Nikolas Lessmann
CSClara I. Sánchez
Clara I. Sánchez
LBL Beenen
L Beenen
LBLuuk H. Boulogne
Luuk H. Boulogne
MBMonique Brink
Monique Brink
BGBram van Ginneken
Bram van Ginneken
Background The COVID-19 pandemic has spread across the globe with alarming speed, morbidity and mortality. Immediate triage of suspected patients with chest infections caused by COVID-19 using ches...

30 March 2017 in Thorax
Verified
Journal Article
Closed access
PDF file
UYUraujh Yousaf-Khan
Uraujh Yousaf-Khan
CACarlijn van der Aalst
Carlijn van der Aalst
PJPim A de Jong
Pim A de Jong
MHMarjolein Heuvelmans
Marjolein Heuvelmans
ESErnst Scholten
Ernst Scholten
HKHarry de Koning
Harry de Koning
Background Debate about the optimal lung cancer screening strategy is ongoing. In this study, previous screening history of the Dutch-Belgian Lung Cancer Screening trial (NELSON) is investigated on if it predicts the screening outcome (test result and lung cancer risk) of the final screening round. Methods 15 792 participants were randomised (1:1) of which 7900 randomised into a screening group. CT screening took place at baseline, and after 1, 2 and 2.5 years. Initially, three screening outcomes were possible: negative, indeterminate or positive scan result. Probability for screening outcome in the fourth round was calculated for subgroups of participants. Results Based on results of the first three rounds, three subgroups were identified: (1) those with exclusively negative results (n=3856; 73.0%); (2) those with ≥1 indeterminate result, but never a positive result (n=1342; 25.5%); and (3) with ≥1 positive result (n=81; 1.5%). Group 1 had the highest probability for having a negative scan result in round 4 (97.2% vs 94.8% and 90.1%, respectively, p<0.001), and the lowest risk for detecting lung cancer in round 4 (0.6% vs 1.6%, p=0.001). ‘Smoked pack-years’ and ‘screening history’ significantly predicted the fourth round test result. The third round results implied that the risk for detecting lung cancer (after an interval of 2.5 years) was 0.6% for those with negative results compared with 3.7% of those with indeterminate results. Conclusions Previous CT lung cancer screening results provides an opportunity for further risk stratifications of those who undergo lung cancer screening. Trial registration number Results, ISRCTN63545820.

1 November 2021 in Radiology: Artificial Intelligence
Verified
Journal Article
Closed access
CJColin Jacobs
Colin Jacobs
ASArnaud A. A. Setio
Arnaud A. A. Setio
ESErnst T. Scholten
Ernst T. Scholten
PGPaul K. Gerke
Paul K. Gerke
HBHaimasree Bhattacharya
Haimasree Bhattacharya
KFKeyvan Farahani
Keyvan Farahani
An observer study showed that two of the three top-performing algorithms from a public competition (Kaggle Data Science Bowl 2017) attained performances that were not significantly worse than that ... Purpose To determine whether deep learning algorithms developed in a public competition could identify lung cancer on low-dose CT scans with a performance similar to that of radiologists. Materials...